WebMD cuts 250 jobs amid ad slump

Share this article:
WebMD cuts 250 jobs amid ad slump
WebMD cuts 250 jobs amid ad slump

WebMD is laying off 14% of its workforce in hopes of saving $45 million to offset revenue losses from an ad slump that plagued the portal throughout 2012.

Around 250 jobs will be eliminated as part of what the company called a broader effort to streamline operations, cut costs and increase user engagement.

“WebMD's value proposition for users continues to be very strong,” said a statement from CEO Cavan Redmond, who joined the firm from Pfizer last summer. “Becoming leaner and more nimble will enable the company to extend our leadership in this highly dynamic and increasingly demanding marketplace.”

WebMD has, in recent months, initiated a redesign of its print mag and a rethink of how its different access points fit together, with special emphasis on upping its game in mobile media. Those moves have garnered a noticeable spike in traffic—the site saw double-digit increases in unique visitors and page views in the third quarter—but haven't yet moved the needle on revenue, which sank 13% for the third quarter over the same period in 2011, to $117 million. Sponsorship and public portal advertising fell 15% to $96.7 million.

The decline of the big, mass-market blockbuster drugs is partly to blame for the slump, but the portal has also faced increasing pressure from more nimble competitors like EverydayHealth, which saw advertising and sponsorship revenues from healthcare companies rise 35% for the first half of the year (EverydayHealth does not divulge its revenue figures, but based on numbers that they put out during a flirtation with an IPO two years ago, they remain much smaller in terms of dollars).

As part of the restructuring, the company said it will “streamline its sales and delivery processes to enable better collaboration with our sponsor and agency clients,” while watching costs more closely, with “a sharper focus on prioritizing resources and investment to key areas of future growth.”
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets

Private View: New ways to engage with customers

Private View: New ways to engage with customers

These healthcare social media campaigns successfully use emotion, altruism and the human desire to "brand" oneself to get customers engaged.